ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: To this purpose, we stratified the CML patients according to their BCR-ABL1/ABL1IS transcript level into three groups (Group A, B and C) and then we compared Ct value obtained from matched specimens counted by the five different methods.